|
Name |
2-Dodecanone
|
Molecular Formula | C12H24O | |
IUPAC Name* |
dodecan-2-one
|
|
SMILES |
CCCCCCCCCCC(=O)C
|
|
InChI |
InChI=1S/C12H24O/c1-3-4-5-6-7-8-9-10-11-12(2)13/h3-11H2,1-2H3
|
|
InChIKey |
LSKONYYRONEBKA-UHFFFAOYSA-N
|
|
Synonyms |
2-Dodecanone; Dodecan-2-one; 6175-49-1; Decyl methyl ketone; METHYL DECYL KETONE; Dodecanone-(2); P5CN8YSV3P; CHEBI:89284; EINECS 228-222-5; UNII-P5CN8YSV3P; MFCD00015064; n-DECYL METHYL KETONE; AI3-28136; 2-Dodecanone, 95%; SCHEMBL103221; CHEMBL2228472; DTXSID4022236; ZINC2034113; 2-Dodecanone, >=97.0% (GC); LMFA12000163; AKOS009158766; NCGC00166062-01; AS-14475; 2-Dodecanone, analytical reference material; CS-0314654; D1862; FT-0612190; D89937; A833406; Q27161470
|
|
CAS | 6175-49-1 | |
PubChem CID | 22556 | |
ChEMBL ID | CHEMBL2228472 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 184.32 | ALogp: | 4.6 |
HBD: | 0 | HBA: | 1 |
Rotatable Bonds: | 9 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 17.1 | Aromatic Rings: | 0 |
Heavy Atoms: | 13 | QED Weighted: | 0.474 |
Caco-2 Permeability: | -4.563 | MDCK Permeability: | 0.00001490 |
Pgp-inhibitor: | 0.118 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.005 | 20% Bioavailability (F20%): | 0.998 |
30% Bioavailability (F30%): | 0.997 |
Blood-Brain-Barrier Penetration (BBB): | 0.978 | Plasma Protein Binding (PPB): | 95.37% |
Volume Distribution (VD): | 1.066 | Fu: | 3.51% |
CYP1A2-inhibitor: | 0.855 | CYP1A2-substrate: | 0.561 |
CYP2C19-inhibitor: | 0.529 | CYP2C19-substrate: | 0.362 |
CYP2C9-inhibitor: | 0.321 | CYP2C9-substrate: | 0.941 |
CYP2D6-inhibitor: | 0.03 | CYP2D6-substrate: | 0.311 |
CYP3A4-inhibitor: | 0.089 | CYP3A4-substrate: | 0.094 |
Clearance (CL): | 5.363 | Half-life (T1/2): | 0.528 |
hERG Blockers: | 0.114 | Human Hepatotoxicity (H-HT): | 0.019 |
Drug-inuced Liver Injury (DILI): | 0.141 | AMES Toxicity: | 0.005 |
Rat Oral Acute Toxicity: | 0.034 | Maximum Recommended Daily Dose: | 0.03 |
Skin Sensitization: | 0.846 | Carcinogencity: | 0.068 |
Eye Corrosion: | 0.988 | Eye Irritation: | 0.957 |
Respiratory Toxicity: | 0.493 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000399 | 0.923 | D05ATI | 0.482 | ||||
ENC000265 | 0.917 | D07ILQ | 0.477 | ||||
ENC000451 | 0.833 | D0Z5BC | 0.469 | ||||
ENC000642 | 0.800 | D03ZJE | 0.439 | ||||
ENC000270 | 0.756 | D0XN8C | 0.439 | ||||
ENC000454 | 0.750 | D0O1PH | 0.437 | ||||
ENC000487 | 0.714 | D0Z5SM | 0.429 | ||||
ENC000472 | 0.705 | D0Y8DP | 0.426 | ||||
ENC000102 | 0.705 | D0E4WR | 0.392 | ||||
ENC000260 | 0.696 | D0G2KD | 0.380 |